FREN

Forgot your password ?

New user? Create an account
DemoSubscribe
Your personalized regulatory consulting
Regulation
All articles
European Commission
SCCS
ECHA
France
IFRA
International
Focus
The checklists

Regulation:SCCS

Hydroxycitronellal, Glyoxylic Acid: Requests for Opinions to the SCCSSubscribers only

On April 30, the SCCS (Scientific Committee on Consumer Safety) approuved, by written procedure, two mandates from the European Commission: one concerns the safety assessment of Hydroxycitronellal, and the other that of Glyoxylic Acid.

Acetophenone: preliminary Opinion of the SCCSSubscribers only

Following the opinion of the RAC (Risk Assessment Committee) of the ECHA (European Chemicals Agency), which recommended classifying Acetophenone as Rep. 1B, the Commission mandated the SCCS to assess the safety of the substance in cosmetics. The Scientific Committee has just published its preliminary Opinion.

Micron-sized Silver : final version of the SCCS' Scientific AdviceSubscribers only

In October 2025, the SCCS accepted the European Commission’s mandate to evaluate the safety of micron-sized particulate Silver in cosmetic products. The Scientific Committee on Consumer Safety has just published the final version of its Scientific Advice.

Cannabidiol: final version of the SCCS' Scientific AdviceSubscribers only

In January 2025, the SCCS accepted the European Commission’s mandate to assess the safety of Cannabidiol. The Scientific Committee on Consumer Safety has just published its final Scientific Advice.

BHA: final version of the SCCS Scientific AdviceSubscribers only

As part of the assessment of substances that may have endocrine disrupting properties, the European Commission has asked the SCCS to evaluate the safety of Butylated Hydroxyanisole (BHA). The Scientific Committee has just published the final version of its Scientific Advice.
Monday, April 24, 2023
Benzophenone-4, Benzophenone-1, Triphenyl Phosphate: requests for Opinions to the SCCSSubscribers only
Following the publication of a list of suspected endocrine disruptors to be assessed on a priority basis, and the subsequent call for data, the Europe...
Tuesday, April 11, 2023
Silver Zinc Zeolite: preliminary Opinion of the SCCSSubscribers only
Following the submission of a safety dossier by industry, the SCCS has assessed the safety of Silver Zinc Zeolite, a preservative transferred to Annex...
Monday, March 27, 2023
Hydroxyapatite (nano): final Opinion of the SCCSSubscribers only
Following an initial negative opinion from the SCCS, and the submission of new data by industry to defend its use in oral products, Hydroxyapatite (na...
Monday, March 27, 2023
Sodium Bromothymol Blue (C186): final Opinion of the SCCSSubscribers only
Following the mandate given by the European Commission to the SCCS in March 2022, the Scientific Committee has published its final Opinion on the safe...
Monday, February 20, 2023
Hexyl Salicylate: request for Opinion to the SCCSSubscribers only
Following the recommendation of the Risk Assessment Committee (RAC) of the European Chemicals Agency (ECHA) to classify Hexyl Dalicylate as “Toxic for...
Monday, February 20, 2023
HC Blue 18: new request for Opinion to the SCCSSubscribers only
Following the submission of new data by industry on the purity of the substance, the European Commission has requested the SCCS to re-evaluate the saf...
Monday, February 13, 2023
Water-soluble zinc salts: new request for Opinion to the SCCSSubscribers only
Following the submission of new data by Cosmetics Europe, the European Commission has requested the SCCS to re-evaluate the safety of water-soluble zi...
Monday, February 6, 2023
Aluminium: final Opinion of the SCCSSubscribers only
Following the mandate given by the European Commission to the SCCS in May 2021 to extend the safety assessment of aluminium compounds to other product...
Monday, February 6, 2023
α- and β-arbutin: Final Opinion of the SCCSSubscribers only
Following the mandate given by the European Commission to the SCCS in June 2021 due to their potential to release Hydroquinone, a substance prohibited...
Tuesday, January 17, 2023
Hydroxyapatite (nano): new preliminary Opinion of the SCCSSubscribers only
Following an initial negative opinion from the SCCS, and the submission of new data by industry to defend its use in oral products, Hydroxyapatite (na...
Monday, January 2, 2023
Methyl Salicylate: new request for Opinion to the SCCSSubscribers only
Following its harmonised classification as a category 2 reprotoxicant, Methyl salicylate was subject to a safety assessment and opinion of the SCCS pu...
Tuesday, December 20, 2022
Salicylic Acid: preliminary Opinion of the SCCSSubscribers only
Following the mandate given by the European Commission to the SCCS in the context of the safety assessment of substances with potential endocrine disr...
Previous page
Next page